[Federal Register Volume 62, Number 47 (Tuesday, March 11, 1997)]
[Notices]
[Page 11216]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-6008]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Allergy and Infectious Diseases Special Emphasis 
Panel (SEP) meetings:

    Name of SEP: Expanded Research on Emerging Diseases (Telephone 
Conference Call).
    Date: March 27, 1997.
    Time: 10:00 a.m.
    Place: Teleconference, 6003 Executive Boulevard, Solar Bldg., 
Room 4C10, Bethesda, MD 20892, (301) 496-2550.
    Contact Person: Dr. Peter R. Jackson, Scientific Review Adm., 
6003 Executive Boulevard, Solar Bldg., Room 4C10, Bethesda, MD 20892 
(301) 496-2550.
    Purpose/Agenda: To evaluate a grant application.

    Name of SEP: Expanded Research on Emerging Diseases (Telephone 
Conference Call).
    Date: March 27, 1997.
    Time: 1:00 p.m.
    Place: Teleconference, 6003 Executive Boulevard, Solar Bldg., 
Room 4C10, Bethesda, MD 20892, (301) 496-2550.
    Contact Person: Dr. Peter R. Jackson, Scientific Review Adm., 
6003 Executive Boulevard, Solar Bldg., Room 4C10, Bethesda, MD 20892 
(301) 496-2550.
    Purpose/Agenda: To evaluate a grant application.

    Name of SEP: Expanded Research on Emerging Diseases (Telephone 
Conference Call).
    Date: March 27, 1997.
    Time: 2:30 p.m.
    Place: Teleconference, 6003 Executive Boulevard, Solar Bldg., 
Room 4C10, Bethesda, MD 20892, (301) 496-2550.
    Contact Person: Dr. Peter R. Jackson, Scientific Review Adm., 
6003 Executive Boulevard, Solar Bldg., Room 4C10, Bethesda, MD 20892 
(301) 496-2550.
    Purpose/Agenda: To evaluate a grant application.

    These meetings will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.855, 
Immunology, Allergic and Immunologic Diseases Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health.)

    Dated: March 5, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-6008 Filed 3-10-97; 8:45 am]
BILLING CODE 4140-01-M